{"id":279302,"date":"2026-07-16T11:37:17","date_gmt":"2026-07-16T11:37:17","guid":{"rendered":"https:\/\/itpharma.com\/le-perou-nous-accueille-a-nouveau-enzymes-blend-et-nouveautes-disruptives-avec-la-signature-it-pharma\/"},"modified":"2026-07-16T11:37:17","modified_gmt":"2026-07-16T11:37:17","slug":"le-perou-nous-accueille-a-nouveau-enzymes-blend-et-nouveautes-disruptives-avec-la-signature-it-pharma","status":"publish","type":"post","link":"https:\/\/itpharma.com\/fr\/le-perou-nous-accueille-a-nouveau-enzymes-blend-et-nouveautes-disruptives-avec-la-signature-it-pharma\/","title":{"rendered":"Le P\u00e9rou nous accueille \u00e0 nouveau : enzymes blend et nouveaut\u00e9s disruptives avec la signature IT Pharma"},"content":{"rendered":"

Deux ans apr\u00e8s notre premi\u00e8re visite, IT Pharma revient \u00e0 Lima pour participer \u00e0 The Faces, l\u2019un des congr\u00e8s majeurs de m\u00e9decine esth\u00e9tique en Am\u00e9rique latine. La soci\u00e9t\u00e9 y propose une formation sp\u00e9cialis\u00e9e, aux c\u00f4t\u00e9s de la Dre Lucia Ferraz, ainsi que des nouveaut\u00e9s qui fa\u00e7onnent l\u2019avenir du secteur. <\/span><\/b> <\/span><\/p>\n

En 2022, IT Pharma est arriv\u00e9e au P\u00e9rou avec le lancement des gammes Inbiotec et Essentials<\/strong>, marquant le d\u00e9but d\u2019une relation solide avec le march\u00e9 local. Le 7 juin dernier, IT Pharma est revenue \u00e0 Lima dans le cadre du congr\u00e8s The Faces, l\u2019un des \u00e9v\u00e9nements les plus importants<\/strong> de la m\u00e9decine esth\u00e9tique en Am\u00e9rique latine. <\/span> <\/span><\/p>\n

La visita cont\u00f3 con la presencia de \u00c1lvaro L\u00f3pez, Chief Commercial Officer de IT Pharma<\/strong>, quien acompa\u00f1\u00f3 el encuentro como parte de la estrategia de expansi\u00f3n en Latinoam\u00e9rica y apoyo al equipo formativo. En ese contexto, la reconocida La Dre Lucia Ferraz a dirig\u00e9 un atelier th\u00e9orique-pratique <\/strong> sur l\u2019utilisation d\u2019Enzymes Blend, destin\u00e9 aux m\u00e9decins esth\u00e9tiques int\u00e9ress\u00e9s par les techniques d\u2019application et les protocoles personnalis\u00e9s. La session a suscit\u00e9 un grand int\u00e9r\u00eat gr\u00e2ce \u00e0 son approche innovante et \u00e0 l\u2019exp\u00e9rience pratique qu\u2019elle a offerte aux participants. <\/span> <\/span><\/p>\n

En plus de l\u2019atelier, des nouveaut\u00e9s de pointe dans le domaine de la m\u00e9decine esth\u00e9tique r\u00e9g\u00e9n\u00e9rative ont \u00e9t\u00e9 pr\u00e9sent\u00e9es et discut\u00e9es, parmi lesquelles Inbiotec Amber et NXO, deux des produits les plus attendus par les professionnels du secteur. Inbiotec Amber a suscit\u00e9 un vif enthousiasme gr\u00e2ce \u00e0 son <\/span>action de reconstruction cutan\u00e9e<\/span><\/i>, bas\u00e9e sur de l\u2019acide hyaluronique non r\u00e9ticul\u00e9 et de l\u2019acide succinique. De son c\u00f4t\u00e9, NXO, avec sa formulation innovante \u00e0 base de nanov\u00e9sicules exosomales, a \u00e9t\u00e9 mis en avant pour son potentiel \u00e0 red\u00e9finir les traitements r\u00e9g\u00e9n\u00e9ratifs de nouvelle g\u00e9n\u00e9ration. <\/span> <\/span><\/p>\n

Avec sa participation \u00e0 The Faces, IT Pharma r\u00e9affirme son engagement envers le d\u00e9veloppement scientifique, la formation continue des professionnels et la construction de relations solides en Am\u00e9rique latine. Le P\u00e9rou reste un march\u00e9 strat\u00e9gique, avec une communaut\u00e9 m\u00e9dicale ouverte \u00e0 l\u2019innovation et \u00e0 l\u2019exigence technique. <\/span> <\/span><\/p>\n

Merci, P\u00e9rou, de nous avoir accueillis une nouvelle fois avec autant d\u2019enthousiasme !<\/span><\/b> <\/span><\/p>\n

\"sin<\/p>\n

\"sin<\/p>\n","protected":false},"excerpt":{"rendered":"

Deux ans apr\u00e8s notre premi\u00e8re visite, IT Pharma revient \u00e0 Lima pour participer \u00e0 The Faces, l\u2019un des congr\u00e8s majeurs de m\u00e9decine esth\u00e9tique en Am\u00e9rique latine. La soci\u00e9t\u00e9 y propose une formation sp\u00e9cialis\u00e9e, aux c\u00f4t\u00e9s de la Dre Lucia Ferraz, ainsi que des nouveaut\u00e9s qui fa\u00e7onnent l\u2019avenir du secteur. En 2022, IT Pharma est arriv\u00e9e […]<\/p>\n","protected":false},"author":94,"featured_media":279306,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"none","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"","_seopress_social_fb_img_attachment_id":0,"_seopress_social_fb_img_width":0,"_seopress_social_fb_img_height":0,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"les deux","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[],"footnotes":""},"categories":[514],"tags":[],"class_list":["post-279302","post","type-post","status-publish","format-standard","has-post-thumbnail","category-non-classifiee"],"_links":{"self":[{"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/posts\/279302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/users\/94"}],"replies":[{"embeddable":true,"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/comments?post=279302"}],"version-history":[{"count":0,"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/posts\/279302\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/media\/279306"}],"wp:attachment":[{"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/media?parent=279302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/categories?post=279302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itpharma.com\/fr\/wp-json\/wp\/v2\/tags?post=279302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}